about
Novel Insights into the Role of Long Noncoding RNA in Ocular DiseasesNRP1 function and targeting in neurovascular development and eye diseaseBone marrow-derived cells in ocular neovascularization: contribution and mechanismsNanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug deliveryTelocytes in regenerative medicineCol4a1 mutations cause progressive retinal neovascular defects and retinopathyDiabetic Macular Edema Pathophysiology: Vasogenic versus InflammatoryThe stereotypical molecular cascade in neovascular age-related macular degeneration: the role of dynamic reciprocityTemsirolimus inhibits proliferation and migration in retinal pigment epithelial and endothelial cells via mTOR inhibition and decreases VEGF and PDGF expressionImatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cellsPooling and Analysis of Published in Vitro Data: A Proof of Concept Study for the Grouping of Nanoparticles.Telocytes and stem cells in limbus and uvea of mouse eyeOxygen delivery, consumption, and conversion to reactive oxygen species in experimental models of diabetic retinopathyAnti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.Role of hypoxia-inducible factor-1α and survivin in oxygen-induced retinopathy in mice.Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-AMicroRNA-410 reduces the expression of vascular endothelial growth factor and inhibits oxygen-induced retinal neovascularization.Development of gene therapy for treatment of age-related macular degeneration.Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularizationEffect of chromogranin A-derived vasostatin-1 on laser-induced choroidal neovascularization in the mouse.Oxidative stress in myopia.Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases.Inhibitory effect of Samul-tang on retinal neovascularization in oxygen-induced retinopathyThe peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease.Intravitreal Topotecan Inhibits Laser-induced Choroidal Neovascularization in a Rat Model.Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab InjectionmiR-126 Regulation of Angiogenesis in Age-Related Macular Degeneration in CNV Mouse Model.Cnidium officinale extract and butylidenephthalide inhibits retinal neovascularization in vitro and in vivoTargeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.A Sema3C Mutant Resistant to Cleavage by Furin (FR-Sema3C) Inhibits Choroidal Neovascularization.A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularizationVitamin D receptor agonists regulate ocular developmental angiogenesis and modulate expression of dre-miR-21 and VEGF.Long-term consequences of developmental vascular defects on retinal vessel homeostasis and function in a mouse model of Norrie disease.microRNA-218 Inhibits Oxygen-induced Retinal Neovascularization via Reducing the Expression of Roundabout 1The Eyes Absent Proteins in Developmental and Pathological Angiogenesis.Serum vascular endothelial growth factor receptor-2 and adropin levels in age-related macular degenerationRepression of retinal microvascular endothelial cells by transthyretin under simulated diabetic retinopathy conditions.The Application of OCTA in Assessment of Anti-VEGF Therapy for Idiopathic Choroidal NeovascularizationSmall Molecular-Sized Artesunate Attenuates Ocular Neovascularization via VEGFR2, PKCα, and PDGFR Targets.Transthyretin represses neovascularization in diabetic retinopathy.
P2860
Q26752617-DE1F24D7-BCF8-4F4F-9009-8798E03A4245Q26765952-BC75E1B9-0240-4FE1-A6F9-4A1F13A688B1Q26765959-EAFCD7C8-080C-4A90-A162-A7BC5E406DEEQ27007119-20D2E3CD-1E9E-4EDD-AEFF-04F579C01EA5Q27012708-60F6A9A7-82A6-4BA2-8450-EC5BBC26FDFFQ27303061-F264C440-20AD-49CE-809D-8D249595AB89Q28070894-02EE97D4-C8A1-40D7-BED6-A454B5F7347CQ28085495-4110A58D-B22D-4539-A7D9-64B093CC04E5Q28540142-1FFF7706-687D-4578-966B-23B73D5AD9E4Q30579734-161BD0EE-9F35-4662-933F-927528FC7149Q31018385-F7F6B20A-CD04-40A1-B923-666D3E4245E3Q31134327-1CBA7099-14D8-425A-8A6A-D33C107EAE06Q33737370-DDA3F1A1-50D8-4C83-92FD-EBD0CE638B4CQ34473329-1AE7FC0B-CAD7-4E88-B91D-318D26BD4642Q34501989-E19A6E50-3387-424D-8EDF-20D971132B60Q35024891-5FACF3C9-7D78-49A4-B6C3-F070ACFE1EB2Q35159008-ACB6E8DB-9D96-4FD6-9680-8593780F399AQ35192906-4F7B1D32-8C78-4AB6-9CF4-49F45E5C6333Q35224472-74566A6B-92F2-4CF6-93D2-5CC4D109CE53Q35290660-03ADFB78-5872-412F-A8F6-3B0E3BCA6B50Q35422039-9BC23F97-96DB-4454-BDBC-28F4580A0C23Q35448249-FDA9A32E-D449-48A4-B086-8214FF7C64C2Q35743028-9050B94E-FA02-4086-A734-992292AAB460Q35807878-5A865699-56BE-4B89-9004-3B9D5E21DC13Q35884935-28011368-3456-4F57-8C83-507BB6498AC8Q35897929-B6C1E452-347B-4965-9F1F-465542E596C2Q36060465-DD8126F8-AE83-4E11-A969-300B04727564Q36082268-C13D29EC-59B1-4203-8F09-563AA961288CQ36164238-1CB0AD01-4BC5-46F5-B607-E3C66C196DABQ36236304-D0C259A1-96D5-4B8A-8A6F-4A7E9B91BC7CQ36319263-B525B88F-8010-4D4B-BF0D-DD4F5D697F08Q36382635-A62A1210-FA70-43CA-BA39-AECAF470BF02Q36391124-77B7A911-CF73-4731-8237-ADD284A7E204Q36720006-8A3342CD-D75B-4628-8BC3-E219E02F0D9DQ36753726-497F352C-C2F6-40C5-A60A-A604118EDB10Q36858963-EFF27363-F750-4D75-9410-D61E16BFD8FAQ37026770-3DBA12F4-D3AD-4A69-90A9-2273F8B4427BQ37100633-3AB63AF9-DDF2-4F54-B00F-1A74B62A9AE4Q37144488-412D6893-8970-42A1-A8B5-A590047BFAB1Q37337158-ABEB8C4B-D66A-4AA5-90F0-DB7A4CEBB750
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Ocular neovascularization.
@en
type
label
Ocular neovascularization.
@en
prefLabel
Ocular neovascularization.
@en
P2860
P1476
Ocular neovascularization.
@en
P2093
Peter A Campochiaro
P2860
P2888
P304
P356
10.1007/S00109-013-0993-5
P577
2013-01-18T00:00:00Z
P6179
1011622382